Bill Gates’ fund targets Alzheimer’s

Bill Gates announced today he is making a personal investment to support the ongoing fight against Alzheimer’s. Writing on his gatesnotes website, he said he would invest $50 million in a Dementia Discovery ...

Biotechs target Alzheimer’s

(USA) A number of leading biotechnology companies are focussing their efforts on conquering Alzheimer's. Last week we reported M3 Biotechnology is developing a drug with the potential to halt the disease....

New drug could ‘halt’ Alzheimer’s

(USA) A potentially game-changing Alzheimer's therapy is to undergo clinical trials in America. Pre-clinical studies carried out by M3 Biotechnology, headquartered in Seattle, of its NDX-1017 drug, showed...